CDH2 and colonic neoplasm: Western blot assay revealed that BRU inhibits the EMT of cancer cells by upregulating the expression of E-cadherin and downregulating the protein levels of Vimentin, N-cadherin, MMP2, and MMP9, thus hindering the metastasis of colon cancer cells.